Francisco Vives

ORCID: 0000-0003-2061-1004
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • International Arbitration and Investment Law
  • Parkinson's Disease Mechanisms and Treatments
  • Taxation and Legal Issues
  • Mediterranean and Iberian flora and fauna
  • Neuropeptides and Animal Physiology
  • Human Rights and Immigration
  • Renin-Angiotensin System Studies
  • Neuroendocrine regulation and behavior
  • Neurotransmitter Receptor Influence on Behavior
  • Historical and socio-economic studies of Spain and related regions
  • Circadian rhythm and melatonin
  • Neuroscience and Neuropharmacology Research
  • International Law and Aviation
  • Marine Biology and Ecology Research
  • Comparative constitutional jurisprudence studies
  • Stress Responses and Cortisol
  • Neurological diseases and metabolism
  • Legal processes and jurisprudence
  • Peptidase Inhibition and Analysis
  • International Law and Human Rights
  • RNA regulation and disease
  • Marine Ecology and Invasive Species
  • Comparative International Legal Studies
  • Hormonal Regulation and Hypertension
  • Memory and Neural Mechanisms

Universidad de Alcalá
2011-2025

Universidad de Granada
2013-2024

Instituto de Investigación Biosanitaria de Granada
2019-2022

Genomics England
2021

Hospital Universitario Fundación Jiménez Díaz
2020

Universidad Internacional
2017

Consejo Superior de Investigaciones Científicas
2008-2011

University of Alicante
2009

Instituto de Neurociencias
2004-2005

Cecil College
2005

We evaluated the role of melatonin in endotoxemia caused by lipopolysaccharide (LPS) unanesthetized rats. The expression inducible isoform nitric oxide synthase (iNOS) and increase oxidative stress seem to be responsible for failure lungs, liver, kidneys endotoxemia. Bacterial LPS (10 mg/kg b. w) was i.v. injected 6 h before rats were killed (10-60 b.w.) i.p. and/or after LPS. Endotoxemia associated with a significant rise serum levels aspartate alanine aminotransferases,...

10.1096/fasebj.13.12.1537 article EN The FASEB Journal 1999-09-01

Alpha-synuclein (alpha-syn) is an intracellular protein with a high tendency to aggregation. It the major component of Lewy bodies and may play key role in pathogenesis Parkinson's disease (PD). alpha-Syn also released by neurons can be detected biological fluids, such as plasma. The purpose this study was determine whether plasma alpha-syn concentrations are elevated newly diagnosed PD patients before treatment (nontreated group, ntPD; n = 53) compare them at least 1 year specific (tPD; 42)...

10.1002/mds.22928 article EN Movement Disorders 2010-01-08
Sara Bandrés‐Ciga Sarah Ahmed Marya S. Sabir Cornelis Blauwendraat Astrid Adarmes‐Gómez and 90 more Inmaculada Bernal‐Bernal Marta Bonilla‐Toribio Dolores Buiza‐Rueda Fátima Carrillo Mario Carrión‐Claro Pilar Gómez‐Garre Silvia Jesús Miguel A. Labrador‐Espinosa Daniel Macías Carlota Méndez‐del‐Barrio María Teresa Periñán Cristina Tejera‐Parrado Laura Vargas‐González Mónica Díez-Fairén Ignacio Álvarez Juan Pablo Tartari Maríateresa Buongiorno Miquel Aguilar Ana Gorostidi J Bergareche Elisabet Mondragón Ana Vinagre‐Aragón Ioana Croitoru Javier Ruiz‐Martínez Oriol Dols‐Icardo Jaime Kulisevsky Juan Marín‐Lahoz Javier Pagonabarraga Berta Pascual‐Sedano Mario Ezquerra Anna Maria Novella Càmara Yaroslau Compta Manel Fernández Rubén Fernández‐Santiago Esteban Muñoz Eduard Tolosa Francesc Valldeoriola Isabel González Aramburu A Rodríguez María Sierra Manuel Menéndez‐González Marta Blázquez Estrada Ciara García Esther Suarez‐San Martin Pedro Ruiz Juan Carlos Martínez‐Castrillo Lydia Vela Clara Ruz Francisco Javier Barrero Francisco Escamilla‐Sevilla Adolfo Mínguez‐Castellanos Debora Cerdan César Tabernero María José Gómez Heredia Francisco Pérez Errazquin Manolo Romero‐Acebal Cici Feliz José Luis López-Sendón Marina Mata Irene Martínez‐Torres Jonggeol Jeffrey Kim Clifton L. Dalgard Janet Brooks Sara Sáez-Atiénzar J. Raphael Gibbs Rafael Jorda Juan A. Botía Luis Bonet‐Ponce Karen Morrison Carl E Clarke Manuela Tan Huw R. Morris Connor Edsall Dena Hernández Javier Simón‐Sánchez Mike A. Nalls Sonja W. Scholz Adriano Jiménez‐Escrig J. Duarte Francisco Vives Raquel Durán Janet Hoenicka Victoria Álvarez Jon Infante Marı́a José Martı́ Jordi Clarimón Adolfo López de Munain Pau Pástor Pablo Mir Andrew Singleton

The Iberian Peninsula stands out as having variable levels of population admixture and isolation, making Spain an interesting setting for studying the genetic architecture neurodegenerative diseases.

10.1002/mds.27864 article EN Movement Disorders 2019-10-29

Degeneration of nigrostriatal dopaminergic neurons is the major pathogenic substrate Parkinson's disease (PD). Inhibitors monoamine oxidase B (MAO‐B) have been used in treatment PD and at least one them, i.e., deprenyl, also displays antioxidant activity. Dopamine (DA) autoxidation produces reactive oxygen species implicated loss pathway. In this study we compared effects melatonin with those deprenyl vitamins E C preventing hydroxyl radical (•OH) generation during DA oxidation. The rate...

10.1034/j.1600-079x.2000.290206.x article EN Journal of Pineal Research 2000-09-01

Reseña de la obra colectiva coordinada por Digno Montalván-Zambrano e Isabel Wences, La justicia detrás Justicia. Ideas y valores políticos en Corte Interamericana Derechos Humanos. Madrid: Marcial Pons, 2023, 302 pp.

10.37536/aielat.2024.1.2672 article ES cc-by 2025-01-13

Presentación del Anuario IELAT

10.37536/aielat.2024.1.2794 article ES 2025-01-13

Tryptophan is mainly metabolized in the brain through methoxyindole and kynurenine pathways. The pathway produces (among other compounds) melatonin, which displays inhibitory effects on human animal central nervous systems, including a significant attenuation of excitatory, glutamate‐mediated responses. kynurenines that interact with Nitric oxide (NO) increases glutamate release, melatonin may act via modification NO synthesis. In present study, four synthetic were studied activity rat...

10.1046/j.1365-2826.1998.00203.x article EN Journal of Neuroendocrinology 1998-04-01

Abstract: We examined the effect of melatonin on brain levels amino acids and nitric oxide (NO) after pentylenetetrazole (PTZ)‐induced seizures in rats. Animals were treated with (10–160 mg/kg, i.p.) 30 min before PTZ administration (100 s.c.), killed 3 hr later. At dose 80 significantly increased latency (5.7–12.7 min) decreased duration (31.2–18.4 s) first seizure, reducing induced mortality from 87.5 to 25%. After kill, brains removed neurotransmitters nitrite measured prefrontal cortex...

10.1034/j.1600-079x.2003.00055.x article EN Journal of Pineal Research 2003-06-16

Abstract The effects of melatonin, amlodipine, diltiazem ( l ‐type Ca 2+ channel blockers) and ω‐conotoxin N blocker) on the glutamate‐dependent excitatory response striatal neurones to sensory‐motor cortex stimulation was studied in a total 111 neurones. Iontophoresis melatonin produced significant attenuation 85.2% with latency period 2 min. either ‐ or blocker also more than 50% recorded without latency. simultaneous iontophoresis + amlodipine did not increase by alone. However,...

10.1046/j.1365-2826.2001.00656.x article EN Journal of Neuroendocrinology 2001-05-01

The excitatory response to motor cortex stimulation of 201 striatal neurones was recorded electrophysiologically test the effects melatonin (aMT) and/or D1 and D2 antagonists. Iontophoresis aMT attenuated in 68.5% neurones, with a latency 2-4 min enhanced 11.9% neurones; 19.6% showed no change response. sulpiride (D2 antagonist) produced an immediate increase 62.8% attenuation 2.3% 34.9%. ejection counteracted aMT-dependent inhibition neurones. SCH-23390 (D1 iontophoresis had significant...

10.1097/00001756-199601310-00053 article EN Neuroreport 1996-01-01
Coming Soon ...